Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 3, 1998, Pages 315-320

  Hanaki, H ^a   Labischinski, H ^b   Inaba, Y ^a   Kondo, N ^a   Murakami, H ^c   Hiramatsu, K ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b BAYER AG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PEPTIDE; PEPTIDOGLYCAN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; NONHUMAN; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

AMINO ACIDS; DRUG RESISTANCE, MICROBIAL; GLUTAMINE; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDOGLYCAN; PHENOTYPE; PROTEIN CONFORMATION; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 0031712697     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.3.315     Document Type: Article

References (23)

1. Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S. et al. (1997). Dissemination in Japanese Hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 1670-1.
2. Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy 40, 135-6.
3. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
4. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.
5. Watanakunakorn, C. (1988). In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin. Journal of Antimicrobial Chemotherapy 22, 321-4.
6. Watanakunakorn, C. (1990). In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin. Journal of Antimicrobial Chemotherapy 25, 69-72.
7. Shlaes, D. M. & Shlaes, J. H. (1995). Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin. Clinical Infectious Diseases 20, 1071-3.
8. Hanaki, H., Kuwahara-Arai, K., Boyle-Vavra, S., Daum, R. S., Labischinski, H. & Hiramatsu, K. (1998). Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. Journal of Antimicrobial Chemotherapy 42, 199-209.
9. Ryffel, C., Strassle, A., Kayser, F. H. & Berger-Bachi, B. (1994). Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 38, 724-8.
10. Kopp, U., Roos, M., Wecke, J. & Labischinski, H. (1996). Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? Microbal Drug Resistance 2, 29-41.
11. Hosotsubo, H. (1989). Rapid and specific method for the determination of vancomycin in plasma by high-performance liquid chromatography on an aminopropyl column. Journal of Chromatography 487, 421-7.
12. Stranden, A. M., Ehlert, K., Labischinski, H. & Berger-Bachi, B. (1997). Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. Journal of Bacteriology 179, 9-16.
13. Gustafson, J., Strassle, A., Hachler, H., Kayser, F. H. & Berger-Bachi, B. (1994). The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. Journal of Bacteriology 176, 1460-7.
14. Arthur, M. & Courvalin, P. (1993). Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrobial Agents and Chemotherapy 37, 1563-71.
15. Dutka-Malen, S., Leclercq, R., Coutant, V., Duval, J. & Courvalin, P. (1990). Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 34, 1875-9.
16. Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A. et al. (1998). Characterization of staphylococci with reduced susceptibility to vancomycin and other glycopeptides. Journal of Clinical Microbiology 36, 1020-7.
17. Reynolds, P. E. (1989). Structure, biochemistry and mechanism of action of glycopeptide antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 8, 943-50.
18. Roos, M., Pittenauer, E., Schmid, E., Beyer, M., Reinike, B., Allmaier, G. et al. (1998). Improved high-performance liquid chromatographic separation of peptidoglycan isolated from various Staphylococcus aureus strains for mass spectrometric characterization. Journal of Chromatography B, Biomedical Sciences and Applications 705, 183-92.
19. Stranden, A. M., Roos, M. & Berger-Bachi, B. (1996). Glutamine synthetase and heteroresistance in methicillin-resistant Staphylococcus aureus. Microbial Drug Resistance 2, 201-7.
20. Siewert, G. & Strominger, J. L. (1968). Biosynthesis of the peptidoglycan of bacterial cell walls. XI. Formation of the isoglutamine amide group in the cell walls of Staphylococcus aureus. Journal of Biological Chemistry 243, 783-90.
21. Nakel, M., Ghuysen, J.-M. & Kandler, O. (1971). Wall peptidoglycan in Aerococcus viridans strains 201 Evans and ATCC 11563 and in Gaffkya homari strain ATCC 10400. Biochemistry 10, 2170-5.
22. Sieradzki, K. & Tomasz, A. (1996). A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus. FEMS Microbiological Letters 142, 161-6.
23. Sieradzki, K. & Tomasz, A. (1997). Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. Journal of Bacteriology 179, 2557-66.